| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
355,150,000 |
| Market
Cap: |
2.30(B) |
| Last
Volume: |
17,273,575 |
Avg
Vol: |
17,226,848 |
| 52
Week Range: |
$6.1 - $10.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
6,313 |
13,261 |
14,828 |
| Total Sell Value |
$0 |
$61,867 |
$119,170 |
$133,715 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
1 |
4 |
7 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Whitaker Anne Clem |
EVP, Company Group Chairman |
• – – |
2016-12-05 |
4/A |
D |
$18.00 |
$108,216 |
D/D |
(6,012) |
158,544 |
|
- |
|
| Rosiello Robert L. |
EVP, Corp Dev & Strategy |
• – – |
2016-12-05 |
4 |
D |
$18.00 |
$264,366 |
D/D |
(14,687) |
517,683 |
|
- |
|
| Whitaker Anne Clem |
EVP, Company Group Chairman |
• – – |
2016-12-05 |
4 |
D |
$18.00 |
$117,090 |
D/D |
(6,505) |
158,885 |
|
- |
|
| Kellen Ari |
EVP, Company Group Chairman |
• – – |
2016-12-05 |
4 |
D |
$18.00 |
$358,776 |
D/D |
(19,932) |
630,842 |
|
- |
|
| Rosiello Robert L. |
EVP, Corp Dev & Strategy |
• – – |
2016-11-04 |
4 |
D |
$22.06 |
$18,023 |
D/D |
(817) |
532,370 |
|
- |
|
| Ingram Robert Alexander |
Director |
– • – |
2016-09-30 |
4 |
A |
$24.55 |
$21,236 |
D/D |
865 |
88,463 |
|
- |
|
| Robertson Russel C |
Director |
– • – |
2016-09-30 |
4 |
A |
$24.55 |
$33,781 |
D/D |
1,376 |
18,414 |
|
- |
|
| Wechsler Amy B |
Director |
– • – |
2016-09-30 |
4 |
A |
$24.55 |
$24,992 |
D/D |
1,018 |
17,969 |
|
- |
|
| Herendeen Paul |
EVP, Chief Financial Officer |
• – – |
2016-08-22 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
150,000 |
|
- |
|
| Appio Thomas |
EVP, COMPANY GROUP CHAIRMANOff |
• – – |
2016-08-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
47,545 |
|
- |
|
| Karabelas Argeris N |
Director |
– • – |
2016-08-11 |
4 |
B |
$24.65 |
$98,600 |
D/D |
4,000 |
20,726 |
2.39 |
- |
|
| Ackermann Christina |
EVP and General Counsel |
• – – |
2016-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
122,762 |
122,762 |
|
- |
|
| Rosiello Robert L. |
EVP, Chief Financial Officer |
• – – |
2016-08-03 |
4 |
D |
$23.54 |
$31,497 |
D/D |
(1,338) |
533,187 |
|
- |
|
| Whitaker Anne Clem |
EVP, Company Group Chairman |
• – – |
2016-08-02 |
4 |
D |
$23.54 |
$19,632 |
D/D |
(834) |
158,544 |
|
- |
|
| Kavanagh Sarah B |
Director |
– • – |
2016-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
14,458 |
14,458 |
|
- |
|
| Valueact Holdings Gp, Llc |
See Remarks |
– • – |
2016-07-01 |
4 |
D |
$23.78 |
$809 |
D/D |
(34) |
17,840 |
|
- |
|
| Eshelman Fredric N |
Director |
– • – |
2016-07-01 |
4 |
D |
$23.78 |
$618 |
D/D |
(26) |
17,796 |
|
- |
|
| Ingram Robert Alexander |
Director |
– • – |
2016-06-30 |
4 |
A |
$20.14 |
$21,751 |
D/D |
1,080 |
87,598 |
|
- |
|
| Robertson Russel C |
Director |
– • – |
2016-06-30 |
4 |
A |
$20.14 |
$6,284 |
D/D |
312 |
17,038 |
|
- |
|
| Wechsler Amy B |
Director |
– • – |
2016-06-30 |
4 |
A |
$20.14 |
$4,532 |
D/D |
225 |
16,951 |
|
- |
|
| Valueact Holdings Gp, Llc |
See Remarks |
– • – |
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
16,726 |
17,874 |
|
- |
|
| Eshelman Fredric N |
Director |
– • – |
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
16,726 |
17,822 |
|
- |
|
| Ross Thomas W. Sr. |
Director |
– • – |
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
16,726 |
17,822 |
|
- |
|
| Power Robert N |
Director |
– • – |
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
16,726 |
32,822 |
|
- |
|
| Ingram Robert Alexander |
Director |
– • – |
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
16,726 |
86,518 |
|
- |
|
705 Records found
|
|
Page 22 of 29 |
|
|
0.04 (0.62%) 
